During the past decade, Omi Medical Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Omi Medical Center" are "Covid19" (2 trials), "Clostridium Difficile Infection" (1 trials), "Endometriosis" (1 trials) and "Uterine Fibroids" (1 trials). Many other conditions were trialed in "Omi Medical Center" in a lesser frequency.

Most popular intervention types in "Omi Medical Center" are "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "BAY1817080" (1 trials), "Clostridium difficile vaccine" (1 trials), "Elagolix" (1 trials) and "K-237 0.3-0.4mg/kg (once daily)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Omi Medical Center" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Omi Medical Center". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Omi Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Omi Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".